Friday, August 29, 2008
 
 
  Home arrow Pregnancy/Development arrow Pregnancy: Human Development in the Uterus arrow Int'l Study: Having More Children Lowers Risk from Breast Cancer Gene (MNT, 5/06)
Main Menu
Home
About Us
Current Headlines
Abortion
Abstinence
Birth Control
End of Life / Euthanasia
Medical Research
Medical Students
Population
Position Statements
Pregnancy/Development
STDs
Stem Cells & Cloning
Contact Us
Web Links
Site Index
Resources
Related Items
Translator
Quotes to Note

The Morning After Pill (MAP, EC): 

"...Researchers have said that it acts in at least 2 ways to end a pregnancy:   

"a.   By damaging the lining of the womb so that implantation of the human embryo - the unseen patient - cannot occur.    

"b. Research in mice has also indicated that if an embryo attaches to the womb, the body reabsorbs it, thereby ending the embryo’s life.    

"Because the MAP can act via these two methods, it must be classified as an abortifacient - a drug that can cause an abortion. The fact that the MAP reduces the expected pregnancy rate by 87% supports the claim that it frequently acts to end the life of a human embryo. Therefore, due to the danger to the health of the human embryo caused by the MAP, my Code of Professional Conduct, parts 1.1 and 1.2,  forbids me from selling this drug." [Policy - Code of Professional Conduct. Pharmaceutical Society of Australia. Endorsed by National Council 3/1998]



 
Int'l Study: Having More Children Lowers Risk from Breast Cancer Gene (MNT, 5/06) PDF Print E-mail

 The International BRCA1/2 Carrier Cohort Study (IBCCS) examined the effect of pregnancy, birth and breastfeeding on women with cancer-causing mutations in the BRCA1 and BRCA2 genes, who have an increased risk of developing breast cancer.

The study [Medical News Today] found that while one pregnancy and birth had no effect on subsequent cancer development for those carrying the mutant genes, a woman's risk of developing breast cancer was lowered substantially when she had more than one child.

Breast cancer rates in women over age 40 dropped 14% with every additional child born. The study also found a difference in cancer development based on the timing of a woman's first child. Women carrying the BRCA2 mutation doubled their risk of developing cancer when they had their first child after age 20, compared to those who gave birth before age 20.

For women carrying the BRCA1 mutation, the opposite was true: women who delayed the birth of their first child until after age 30 lowered their risk of developing breast cancer. Participants in the study all carried a breast cancer gene mutation. 853 had developed breast cancer.

The IBCCS study was carried out by researchers in France, the UK, the Netherlands, Sweden, Germany and Canada. The German Cancer Research Center, Deutsches Krebsforschungszentrum (DKFZ), played a key role in the study. [Medical News Today, 31May06 , LifeSiteNews.com]

 
< Prev   Next >


Go to top of page  Home | About Us | Current Headlines | Abortion | Abstinence | Birth Control | End of Life / Euthanasia | Medical Research | Medical Students | Population | Position Statements | Pregnancy/Development | STDs | Stem Cells & Cloning | Contact Us | Web Links | Site Index | Resources |
 
PhysiciansForLife.org Copyright (C) 2004-2008 All Rights Reserved